• Home
  • About
    • About Panaxea
    • Meet our team
    • Careers
  • Services
    • Health Technology Assessment
    • Health Services & Systems Research
    • Health Innovation Assessment Consultancy
  • News & Cases
  • Publications
  • Contact
  • Privacy Statement Panaxea

Michelle Kip, Helma Monteban & Lotte Steuten, Long-term cost–effectiveness of Oncotype DX® versus current clinical practice from a Dutch cost perspective, Journal of Comparative Effectiveness Research.

Link to publication

Panaxea b.v. supports decision making in healthcare by assessing the relative advantage of healthcare innovations. Our clients include patients, health and life science innovators and investors, health technology adopters, public and private payers, and policymakers.

Follow us on Twitter

Tweets by @PANAXEA

Useful Links

Home
About Panaxea
Services
Publications
Contact Us

Social Media

 Twitter Linkedin

Contact Information

PANAXEA b.v.
Pettelaarpark 84
5216 PP Den Bosch
The Netherlands

+31 20 7400 778
www.panaxea.eu
info@panaxea.eu

© 2019 Panaxea. All Rights Reserved.
  • Privacy Statement Panaxea
  • No translations available for this page